Evidence map›Paper›PMID 19332174›Full record

ArticleOsteoarthritis and cartilage2009

Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes.

A R Shikhman, D C Brinson, J Valbracht, M K Lotz

Open access · greenAbstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Immunomodulatory Effects ofMarine drugs · 2020
    Article
  9. Article
  10. Article
  11. Glucosamine Hydrochloride andTissue engineering and regenerative medicine · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Intra-articular delivery of glucosamine for treatment of experimental osteoarthritis created by a medial meniscectomy in a rat model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A R ShikhmanDivision of Arthritis Research, The Scripps Research Institute, Division of Rheumatology, Scripps Clinic, La Jolla, CA 92037, USA.
D C Brinson
J Valbracht
M K Lotz
Scripps Research Institute · US

Funding

TISSUE ACQUISITION, MORPHOLOGY, AND CELL CULTUREP01AG007996 · NIA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI TERKELTAUB, ROBERT A. · 1989 to 2016
$26.0M
TRAINING PROGRAM IN COMPLEMENTARY &ALTERNATIVE MEDICINET32AT000052 · NCCIH · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TAYLOR, ANN GILL · 2000 to 2010
$3.6M
CHONDROCYTE SUBPOPULATIONS IN AGING AND OSTEOARTHRITISR01AG033409 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI LOTZ, MARTIN K · 2008 to 2008
$544k
GLUCOSAMINE IN CARTILAGE HOMEOSTASIS AND DEGRADATIONK08AT000052 · NCCIH · SCRIPPS RESEARCH INSTITUTE · PI SHIKHMAN, ALEXANDER R · 2000 to 2004
$459k
Safety of intraarticular N-acetylglucosamineR42AT003352 · NCCIH · ARTYX PHARMACEUTICALS, INC. · PI LOTZ, MARTIN K · 2006 to 2008
$397k
NCCIH NIH HHS AT000052NCCIH NIH HHS F32 AT000052NCCIH NIH HHS K08 AT000052NCCIH NIH HHS R42 AT003352NCCIH NIH HHS T32 AT000052NIA NIH HHS AG007996NIA NIH HHS AG033409NIA NIH HHS P01 AG007996NIA NIH HHS R01 AG033409
6 · The paper itself

Abstract

objectiveAminosugars are commonly used to treat osteoarthritis; however, molecular mechanisms mediating their anti-arthritic activities are still poorly understood. This study analyzes facilitated transport and metabolic effects of glucosamine (GlcN) and N-acetylglucosamine (GlcNAc) in human articular chondrocytes.

methodsHuman articular chondrocytes were isolated from knee cartilage. Facilitated transport of glucose, GlcN and GlcNAc was measured by uptake of [3H]2-deoxyglucose, [3H]GlcN and [3H]GlcNAc. Glucose transporter (GLUT) expression was analyzed by Western blotting. Production of sulfated glycosaminoglycans (SGAG) was measured using [(35)S]SO4. Hyaluronan was quantified using hyaluronan binding protein.

resultsChondrocytes actively import and metabolize GlcN but not GlcNAc and this represents a cell-type specific phenomenon. Similar to facilitated glucose transport, GlcN transport in chondrocytes is accelerated by cytokines and growth factors. GlcN non-competitively inhibits basal glucose transport, which in part depends on GlcN-mediated depletion of ATP stores. In IL-1beta-stimulated chondrocytes, GlcN inhibits membrane translocation of GLUT1 and 6, but does not affect the expression of GLUT3. In contrast to GlcN, GlcNAc accelerates facilitated glucose transport. In parallel with the opposing actions of these aminosugars on glucose transport, GlcN inhibits hyaluronan and SGAG synthesis while GlcNAc stimulates hyaluronan synthesis. GlcNAc-accelerated hyaluronan synthesis is associated with upregulation of hyaluronan synthase-2.

conclusionDifferences in GlcN and GlcNAc uptake, and their subsequent effects on glucose transport, GLUT expression and SGAG and hyaluronan synthesis, indicate that these two aminosugars have distinct molecular mechanisms mediating their differential biological activities in chondrocytes.

Indexed as

Cartilage, ArticularCells, CulturedChondrocytesFucoseGlucosamineHumansImmunohistochemistryKnee JointOsteoarthritisFucoseGlucosamineN-acetylfucosamine

Identifiers

PMID19332174
PMCPMC2785807
OpenAlexW2061367562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.